Literature DB >> 15448739

Nitric oxide and platelet energy metabolism.

Marian Tomasiak1, Halina Stelmach, Tomasz Rusak, Jolanta Wysocka.   

Abstract

This study was undertaken to determine whether nitric oxide (NO) can affect platelet responses through the inhibition of energy production. It was found that NO donors: S-nitroso-N-acetylpenicyllamine, SNAP, (5-50 microM) and sodium nitroprusside, SNP, (5-100 microM) inhibited collagen- and ADP-induced aggregation of porcine platelets. The corresponding IC50 values for SNAP and SNP varied from 5 to 30 microM and from 9 to 75 microM, respectively. Collagen- and thrombin-induced platelet secretion was inhibited by SNAP (IC50 = 50 microM) and by SNP (IC50 = 100 microM). SNAP (20-100 microM), SNP (10-200 microM) and collagen (20 microg/ml) stimulated glycolysis in intact platelets. The degree of glycolysis stimulation exerted by NO donors was similar to that produced by respiratory chain inhibitors (cyanide and antimycin A) or uncouplers (2,4-dinitrophenol). Neither the NO donors nor the respiratory chain blockers affected glycolysis in platelet homogenate. SNAP (20-100 microM) and SNP (50-200 microM) inhibited oxygen consumption by platelets. The effect of SNP and SNAP on glycolysis and respiration was not reduced by 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one, a selective inhibitor of NO-stimulated guanylate cyclase. SNAP (5-100 microM) and SNP (10-300 microM) inhibited the activity of platelet cytochrome oxidase and had no effect on NADH:ubiquinone oxidoreductase and succinate dehydrogenase. Blocking of the mitochondrial energy production by antimycin A slightly affected collagen-evoked aggregation and strongly inhibited platelet secretion. The results indicate that: 1) in porcine platelets NO is able to diminish mitochondrial energy production through the inhibition of cytochrome oxidase, 2) the inhibitory effect of NO on platelet secretion (but not aggregation) can be attributed to the reduction of mitochondrial energy production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448739     DOI: 045103789

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  5 in total

1.  Inhaled nitric oxide to control platelet hyper-reactivity in patients with acute submassive pulmonary embolism.

Authors:  Jeffrey A Kline; Michael A Puskarich; Jonathan W Pike; John Zagorski; Nathan J Alves
Journal:  Nitric Oxide       Date:  2020-01-12       Impact factor: 4.427

2.  Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients.

Authors:  Leonardo Lorente; María M Martín; Esther López-Gallardo; Ruth Iceta; José Blanquer; Jordi Solé-Violán; Lorenzo Labarta; César Díaz; Alejandro Jiménez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Crit Care       Date:  2014-06-30       Impact factor: 9.097

Review 3.  ROS in Platelet Biology: Functional Aspects and Methodological Insights.

Authors:  Elena Masselli; Giulia Pozzi; Mauro Vaccarezza; Prisco Mirandola; Daniela Galli; Marco Vitale; Cecilia Carubbi; Giuliana Gobbi
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

4.  Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock.

Authors:  Alessandro Protti; Francesco Fortunato; Andrea Artoni; Anna Lecchi; Giovanna Motta; Giovanni Mistraletti; Cristina Novembrino; Giacomo Pietro Comi; Luciano Gattinoni
Journal:  Crit Care       Date:  2015-02-11       Impact factor: 9.097

5.  Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels.

Authors:  Diego Méndez; Diego Arauna; Francisco Fuentes; Ramiro Araya-Maturana; Iván Palomo; Marcelo Alarcón; David Sebastián; Antonio Zorzano; Eduardo Fuentes
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.